Results 91 to 100 of about 8,089 (207)
Pulmonary Circulation, Volume 16, Issue 2, June 2026.ABSTRACT Chronic thromboembolic pulmonary hypertension (CTEPH) is rare in adolescents, and evidence regarding balloon pulmonary angioplasty (BPA) in young patients with hereditary thrombophilia remains limited. A 16year‐old male was diagnosed with CTEPH and protein S deficiency, characterized by markedly low activity and antigen levels.
Hiroyuki Fujii +3 more
wiley +1 more source
Advanced Science, Volume 13, Issue 11, 23 February 2026.Chronic oral exposure to microplastics may disrupt gut microbiota homeostasis and intestinal barrier integrity, potentially engaging the gut–brain axis and systemic inflammatory responses. These alterations may be associated with impaired blood–brain barrier function, cerebral microvascular dysfunction, and enhanced endothelial inflammation, pro ...
Hongxing Wang +5 more
wiley +1 more source
, 2020 Pulmonary endarterectomy (PEA) is a potentially curative procedure for chronic thromboembolic pulmonary hypertension. A 34-year Indian male presented with supra-systemic pulmonary pressure was taken for PEA after achievable optimization. A successful PEA
Katkade, Sandip +3 more
core +1 more source
Pulmonary Hypertension: Diagnosis, Management, and Treatment [PDF]
, 2019 2019-02Pulmonary hypertension (PH) is a hemodynamic state that is characterized by a resting mean pulmonary artery pressure ≧ 25 mmHg. The common forms of PH are pulmonary arterial hypertension (PAH), chronic thromboembolic pulmonary hypertension (CTEPH),
Okumura, Naoki +3 more
core +1 more source
The Thoracic & Cardiovascular Surgeon Reports, 2016 Pulmonary endarterectomy (PEA) due to chronic thromboembolic pulmonary hypertension (CTEPH) is mainly performed in deep hypothermic circulatory arrest without additional cerebroprotective means.
Martin Czerny +4 more
doaj +1 more source
Operative classification of thromboembolic disease determines outcome after pulmonary endarterectomy
, 2002 Objective: We sought to determine whether type and location of thromboembolic disease in the pulmonary vascular tree predicts the hemodynamic result and clinical outcome in patients undergoing pulmonary endarterectomy.
Jamieson, Stuart W. +6 more
core +1 more source
, 2023 Little is known about long‐term quality of life (QOL) and functional status after pulmonary endarterectomy (PEA) for chronic thromboembolic pulmonary hypertension (CTEPH). We investigated QOL and functional status late after PEA.
Fredrik Bredin +14 more
core +1 more source
State-of-the-art chronic thromboembolic pulmonary hypertension diagnosis and management [PDF]
European Respiratory Review, 2012 Chronic thromboembolic pulmonary hypertension (CTEPH) is a debilitating disease caused by chronic obstruction of pulmonary artery branches following episodes of pulmonary embolism and incomplete thrombus resolution.
D. Jenkins +3 more
doaj
, 2017 Background/Purpose: Pulmonary endarterectomy (PEA) is a potentially curative surgical procedure for patients with chronic thromboembolic pulmonary hypertension. The aim of this study is to review our institutional experience with this operation. ;Methods:
林彥宏;黃書健;盤松青;徐紹勛;賴鴻緒;郭順文 +1 more
core +1 more source
Riociguat: an upcoming therapy in chronic thromboembolic pulmonary hypertension?
European Respiratory Review, 2010 Although pulmonary endarterectomy remains the treatment of choice for patients with chronic thromboembolic pulmonary hypertension (CTEPH), not all patients will benefit from or receive this highly specialised surgery.
N. H. Kim
doaj